Discovering Ebola’s Pathway Through Human Skin

Researchers from the University of Iowa Health Care, Texas Biomedical Research Institute, and Boston University made a significant breakthrough in understanding how the Ebola virus (EBOV) navigates through the skin. Their study, published in Science Advances, illuminates the virus’s journey from the lower dermis to the skin’s surface, potentially explaining person-to-person transmission via skin contact.

The Journey of Ebola Through the Skin

The study reveals that EBOV infects at least three distinct cell types in the lower dermis layer, including fibroblasts, endothelial cells, and myeloid cells. These cells act as conduits, facilitating the virus’s progression through the epithelial layer to the skin’s surface. This viral movement occurs within days, indicating a rapid and efficient process.

Identifying Key Players in Viral Infection

Scientific investigation into the mechanisms supporting Ebola infection led to the discovery of critical intracellular receptors. Researchers found that NPC1 (a protein in endosomes) and AXL (a phosphatidylserine receptor) are essential for Ebola to enter both fibroblasts and keratinocytes. These findings highlight the intricate interplay between cellular proteins and viral behavior, which is crucial for developing effective antiviral strategies.

New Insights into Person-to-Person Transmission

Previous studies have shown that Ebola can be found on the skin surface of infected individuals, particularly during the later stages of the disease. This new research suggests that skin could be a contributing factor in the spread of Ebola between people. By understanding how the virus infiltrates the skin, medical professionals may better prevent transmission and implement more effective containment protocols.

Advancing Antiviral Research

The team developed a novel human skin explant model using full-thickness skin biopsies. This model can be used to study EBOV’s infection dynamics and test the efficacy of antiviral treatments. This approach offers a valuable and accessible platform for researchers to evaluate potential treatments before progressing to animal models or clinical trials.

Senior author Michael Maury emphasized the significance of their findings. “Our research not only defines the route EBOV takes through the skin to reach the surface but also identifies key cell types permissive to infection,” he stated. “Understanding this mechanism is critical for developing effective antiviral strategies and preventing transmission from infected individuals.”

The Significance of This Research

This study brings us closer to unraveling the complexities of Ebola infection and transmission. By clarifying how EBOV navigates through the skin, scientists can develop more accurate models for antiviral drug testing and implement better containment strategies. The human skin explant system represents a significant advancement in understanding and combating this deadly disease.

Implications for Future Research

The findings from this study open up new avenues for research into viral transmission and treatment. By identifying critical cellular mechanisms and developing a reliable skin model system, the research community can accelerate the development of antiviral therapies and contribute to effective control of Ebola outbreaks.